These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9187444)

  • 21. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience.
    Lee CK; Aeppli D; Nierengarten ME
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):169-79. PubMed ID: 10924987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease.
    Hancock SL; Hoppe RT
    Semin Radiat Oncol; 1996 Jul; 6(3):225-242. PubMed ID: 10717180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
    N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Second primary tumors in patients treated at an early age for Hodgkin's disease; consequences for the follow-up].
    Aleman BM; Klokman WJ; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1517-20. PubMed ID: 10949633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
    Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second lethal events associated with treatment for Hodgkin's disease: a review of 2980 patients treated in a single Mexican institute.
    Avilés A; Neri N; Cuadra I; Alvarado I; Cleto S
    Leuk Lymphoma; 2000 Oct; 39(3-4):311-9. PubMed ID: 11342311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
    Hancock SL; Donaldson SS; Hoppe RT
    J Clin Oncol; 1993 Jul; 11(7):1208-15. PubMed ID: 8315419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.
    Pedersen-Bjergaard J; Larsen SO
    N Engl J Med; 1982 Oct; 307(16):965-71. PubMed ID: 7110299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects.
    Zijlstra JM; Dressel AJ; Mens JW; Tinteren Hv; Slotman BJ; Jonkhoff AR; Huijgens PC
    Hematol J; 2002; 3(4):179-84. PubMed ID: 12189563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin's lymphoma: evolving concepts with implications for practice.
    Meyer RM; Ambinder RF; Stroobants S
    Hematology Am Soc Hematol Educ Program; 2004; ():184-202. PubMed ID: 15561683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
    Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
    J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P
    Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.